Summary
For Year 2026-27, Pfizer reports the following shareholding: Total Promoters at 63.92%, Mutual Fund at 11.52%, Insurance at 5.31%, Foreign Institutional Investors at 2.81%, Domestic Institutional Investors at 0.06%, and Retail at 16.37%. This breakdown provides a quick snapshot of ownership distribution for Pfizer in 2026-27.
Pfizer FAQs
As of 04-2026, the promoter shareholding in Pfizer stands at 63.92% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Pfizer is 2.81% and 0.06% respectively.
The retail shareholding of the Pfizer is 16.37%.
Changes in shareholding patterns of Pfizer can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Pfizer are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
